ReviewCurrent diabetes reports2011
Cardiovascular disease in chronic kidney disease: data from the Kidney Early Evaluation Program (KEEP).
Review in Current diabetes reports, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 50 citations in OpenAlex.
- Long-term kidney allograft function and survival in prednisone-free regimens: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.Clinical journal of the American Society of Nephrology : CJASN · 2012Trial
- Perirenal fat differs in patients with chronic kidney disease receiving different vitamin D-based treatments: a preliminary study.BMC nephrology · 2025Article
- Article
- Observational
- The Role of Prognostic and Predictive Biomarkers for Assessing Cardiovascular Risk in Chronic Kidney Disease Patients.BioMed research international · 2020Review
- Vitamin D and cardiovascular disease in chronic kidney disease.Pediatric nephrology (Berlin, Germany) · 2019Review
- Folic Acid and Vitamin B12 Administration in CKD, Why Not?Nutrients · 2019Review
- Folic Acid and Homocysteine in Chronic Kidney Disease and Cardiovascular Disease Progression: Which Comes First?Cardiorenal medicine · 2017Review
- Management of Hypertension in Patients with Chronic Kidney Disease.Current hypertension reports · 2017Review
- Histopathological Changes in the Kidney following Congestive Heart Failure by Volume Overload in Rats.Oxidative medicine and cellular longevity · 2017Article
- Aichi cohort study of the prognosis in patients newly initiated into dialysis (AICOPP): baseline characteristics and trends observed in diabetic nephropathy.Clinical and experimental nephrology · 2016Article
- Hemodiafiltration and hemodialysis differently affect P wave duration and dispersion on the surface electrocardiogram.International urology and nephrology · 2016Article
- Management of hypertension in chronic kidney disease.Nature reviews. Nephrology · 2015Review
- Cardiorenal Syndrome and the Role of the Bone-Mineral Axis and Anemia.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2015Review
- Neck Circumference as a Predictive Indicator of CKD for High Cardiovascular Risk Patients.BioMed research international · 2015Article
- The relationship between IL-10 levels and cardiovascular events in patients with CKD.Clinical journal of the American Society of Nephrology : CJASN · 2014Observational
- Racial disparities in kidney disease outcomes.Seminars in nephrology · 2013Article
- Hemodialysis and hemodiafiltration differently modulate left ventricular diastolic function.BMC nephrology · 2013Article
- The synergistic relationship between estimated GFR and microalbuminuria in predicting long-term progression to ESRD or death in patients with diabetes: results from the Kidney Early Evaluation Program (KEEP).American journal of kidney diseases : the official journal of the National Kidney Foundation · 2013Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 3 institutions in 1 country.
Funding
Abstract
Diabetes mellitus (DM) and hypertension (HTN) are leading joint risk factors for both cardiovascular disease (CVD) and chronic kidney disease (CKD). In the nationwide KEEP (Kidney Early Evaluation Program) an estimated glomerular filtration rate less than 60 mL/min/1.73 m(2) or a urine albumin:creatinine ratio ≥30 mg/g (3.4 mg/mmol) defines CKD. Overall in KEEP, the rates of identified CKD and self-reported CVD are 25.7% and 22.1%, respectively. The presence of CKD has been associated with younger ages of self-reported myocardial infarction and stroke. The combination of CVD and CKD in KEEP has been associated with shorter survival time. Finally, the presence of CVD or a prior history of coronary revascularization has been associated with modestly better rates of CVD risk factor control; however, the majority of patients with CKD have suboptimally controlled blood pressure, glucose, or lipids. These data suggest that patients with CKD are not only at higher risk for CVD and subsequent mortality, but are also ideal for targeted community--and practice-based interventions to improve risk factor control and, hopefully, reduce rates of subsequent cardiovacular events.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.